A Study of Enzalutamide in Combination With AZD5363 in Patients With mCRPC (RE-AKT) - Stand Up To Cancer

Blog

Posted October 11, 2019

A Study of Enzalutamide in Combination With AZD5363 in Patients With mCRPC (RE-AKT)

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.

17001
Array
(
    [0] => 8
)
Array
(
    [0] => 8
)
Array
(
    [0] => 8
)